Cytokinetics stock forecast
WebFeb 28, 2024 · Cytokinetics Stock Up 0.4 %. Shares of CYTK opened at $42.98 on Tuesday. Cytokinetics, Incorporated has a 52 week low of $33.10 and a 52 week high of $55.80. The firm has a market cap of $4.07 billion, a P/E ratio of -13.60 and a beta of 0.90. The firm's 50-day simple moving average is $43.66 and its 200 day simple moving … Web2 days ago · The Cytokinetics stock price fell by -3.54% on the last day (Wednesday, 12th Apr 2024) from $35.30 to $34.05. During the last trading day the stock fluctuated 5.99% …
Cytokinetics stock forecast
Did you know?
Web1 day ago · See the latest Cytokinetics Inc stock price (NASDAQ:CYTK), related news, valuation, dividends and more to help you make your investing decisions. WebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle …
Web18 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Cytokinetics (CYTK) ... * Price Target & Stock Forecast ; Full Company Report ... WebApr 5, 2024 · According to analysts' consensus price target of $56.21, Cytokinetics has a forecasted upside of 54.4% from its current price of $36.42. Amount of Analyst Coverage …
WebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% compared with the industry’s decline of 4.7%. WebApr 10, 2024 · 2. Markets Today: Stock Indexes Fall on Weakness in Tech Stocks. 3. Option Volatility And Earnings Report For April 10 - 14. 4. Despite a Potential Devon Energy Dividend Cut, Investors Short Its Puts for Income. 5. Stocks Set to Open Lower as Investors Await FOMC Minutes, Inflation Data.
WebFeb 13, 2024 · Cytokinetics Stock Forecast and Price Target In recent months, two notable analysts have provided yearlong price targets for Cytokinetics, with the average …
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. how is public relations viewed todayWebMar 7, 2024 · Future criteria checks 0/6. Cytokinetics, Incorporated's earnings is forecasted to decline at 23.5% and its revenue is expected to decline at 46.6%. Cytokinetics, Incorporated has a predicted EPS and ROE of 27.5% and -44.7% respectively. how is public transportation fundedWebApr 3, 2024 · Stock Price Forecast. According to 22 stock analysts, the average 12-month stock price forecast for CYTK stock is $ 63.44 , which predicts an increase of 70.72%. … how is public school fundedWebApr 2, 2024 · Posted by MarketBeat News on Apr 2nd, 2024. Shares of Cytokinetics, Incorporated ( NASDAQ:CYTK – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $34 ... how is public school better than privateWebApr 6, 2024 · Cytokinetics initiated with buy rating, $60 price target at Truist Dec. 20, 2024 at 7:41 a.m. ET by Steve Gelsi Cytokinetics started at buy with $80 stock price target at … how is puerto ricoWebApr 10, 2024 · Cytokinetics NasdaqGS:CYTK Stock Report. Last Price. US$34.99. Market Cap. US$3.3b. 7D-7.2%. 1Y-14.8%. Updated. 10 Apr, 2024. Data. Company Financials + 14 Analysts. ... Broker Revenue Forecasts For Cytokinetics, Incorporated (NASDAQ:CYTK) Are Surging Higher Jan 09. Cytokinetics: Biotech That Should Be On Your Radar With … how is publisher different from wordWebMar 3, 2024 · Shareholders in Cytokinetics, Incorporated (NASDAQ:CYTK) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts.The analysts have sharply ... how is puerto rico right now